OneLife Technologies Corp.

OneLife Technologies Corp. operates as a mobile medical hardware, software, and data collection company in the United States and internationally. The company offers a suite of medical grade tracking technologies to provide patients, physicians, nursing homes, and hospitals with real-time comprehensive health data and monitoring. Its products include Sensation, a wearable designed for the health and medical markets who want or need to track aspects of their physical health, such as heart rate, activity, sleep patterns, and location; and Tricorder that captures blood pressure, heart rate, ECG/EKG, SpO2, and temperature from a patient. The company's products also comprise Personal Data Vault that offers the user a data vault, which is the central repository of their health data. OneLife Technologies Corp. is based in Rolling Meadows, Illinois.

OneLife Technologies Corp. trades as OLMM on OTC. The company is classified in Healthcare / Medical - Healthcare Information Services and reports in USD.

The current profile places the business in Medical - Healthcare Information Services. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

OneLife Technologies Corp. can be compared against peers such as Accelera Innovations, Inc, Acutus Medical, Inc., Evelo Biosciences, Inc., GSRX Industries Inc., Healthtech Solutions Inc., iCoreConnect Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $1,005, beta of -61.51, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

OLMM currently shows total debt of N/A and beta of -61.51. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.onelifetc.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.